Johnson-Pais TL - Search Results

1

Prospective comparison of restriction spectrum imaging and non-invasive biomarkers to predict upgrading on active surveillance prostate biopsy.

Eng SE, Basasie B, Lam A, John Semmes O, Troyer DA, Clarke GD, Sunnapwar AG, Leach RJ, Johnson-Pais TL, Sokoll LJ, Chan DW, Tosoian JJ, Siddiqui J, Chinnaiyan AM, Thompson IM Jr, Boutros PC, Liss MA. Eng SE, et al. Among authors: johnson pais tl. Prostate Cancer Prostatic Dis. 2024 Mar;27(1):65-72. doi: 10.1038/s41391-022-00591-w. Epub 2022 Sep 12. Prostate Cancer Prostatic Dis. 2024. PMID: 36097168

2

Extinction of liver/bone/kidney alkaline phosphatase in osteosarcoma hybrid cells.

Johnson-Pais TL, Leach RJ. Johnson-Pais TL, et al. Somat Cell Mol Genet. 1992 Sep;18(5):423-30. doi: 10.1007/BF01233082. Somat Cell Mol Genet. 1992. PMID: 1475709

3

Regulation of osteoblast gene expression in intratypic osteosarcoma hybrid cells.

Johnson-Pais TL, Leach RJ. Johnson-Pais TL, et al. Exp Cell Res. 1995 Dec;221(2):370-6. doi: 10.1006/excr.1995.1387. Exp Cell Res. 1995. PMID: 7493636

4

Confirmation of the assignment of the human tartrate-resistant acid phosphatase gene (ACP5) to chromosome 19.

Leach RJ, Reus BE, Hundley JE, Johnson-Pais TL, Windle JJ. Leach RJ, et al. Genomics. 1994 Jan 1;19(1):180-1. doi: 10.1006/geno.1994.1037. Genomics. 1994. PMID: 8188227 No abstract available.

5

Osteosarcoma hybrids can preferentially target alkaline phosphatase activity to matrix vesicles: evidence for independent membrane biogenesis.

Leach RJ, Schwartz Z, Johnson-Pais TL, Dean DD, Luna M, Boyan BD. Leach RJ, et al. J Bone Miner Res. 1995 Nov;10(11):1614-24. doi: 10.1002/jbmr.5650101103. J Bone Miner Res. 1995. PMID: 8592937 Free article.

6

1,25-Dihydroxyvitamin D3 and transforming growth factor-beta act synergistically to override extinction of liver/bone/kidney alkaline phosphatase in osteosarcoma hybrid cells.

Johnson-Pais TL, Leach RJ. Johnson-Pais TL, et al. Exp Cell Res. 1996 Jul 10;226(1):67-74. doi: 10.1006/excr.1996.0203. Exp Cell Res. 1996. PMID: 8682172

7

Chromosome 18 suppresses the tumorigenicity of prostate cancer cells.

Padalecki SS, Johnson-Pais TL, Killary AM, Leach RJ. Padalecki SS, et al. Genes Chromosomes Cancer. 2001 Mar;30(3):221-9. doi: 10.1002/1098-2264(2000)9999:9999<::aid-gcc1093>3.0.co;2-l. Genes Chromosomes Cancer. 2001. PMID: 11170278

8

Androgen receptor length polymorphism associated with prostate cancer risk in Hispanic men.

Balic I, Graham ST, Troyer DA, Higgins BA, Pollock BH, Johnson-Pais TL, Thompson IM, Leach RJ. Balic I, et al. J Urol. 2002 Nov;168(5):2245-8. doi: 10.1016/S0022-5347(05)64364-9. J Urol. 2002. PMID: 12394768

9

Identification of a novel tandem duplication in exon 1 of the TNFRSF11A gene in two unrelated patients with familial expansile osteolysis.

Johnson-Pais TL, Singer FR, Bone HG, McMurray CT, Hansen MF, Leach RJ. Johnson-Pais TL, et al. J Bone Miner Res. 2003 Feb;18(2):376-80. doi: 10.1359/jbmr.2003.18.2.376. J Bone Miner Res. 2003. PMID: 12568416 Free article.

10

Determination of a minimal region of loss of heterozygosity on chromosome 18q21.33 in osteosarcoma.

Johnson-Pais TL, Nellissery MJ, Ammerman DG, Pathmanathan D, Bhatia P, Buller CL, Leach RJ, Hansen MF. Johnson-Pais TL, et al. Int J Cancer. 2003 Jun 10;105(2):285-8. doi: 10.1002/ijc.11070. Int J Cancer. 2003. PMID: 12673693 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

68 results

Search Page